Financial Summary (All financials)
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 |
| Revenues | 0.8 | 0.7 | 0.7 | 0.1 | |
| Revenue growth | 21.2% | 3.3% | 1029.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross profit | 0.8 | 0.7 | 0.7 | 0.1 | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | |
| Sales and marketing | 1.1 | 1.5 | 1.8 | 0.7 | |
| Research and development | 1.5 | 3.1 | 2.3 | 1.3 | |
| General and administrative | 2.5 | 5.2 | 4.6 | 2.0 | |
| EBIT | -4.2 | -9.1 | -7.7 | -3.9 | |
| EBIT margin | -499.9% | -1299.4% | -1145.2% | -6483.9% | |
| Pre-tax income | -4.2 | -9.1 | -11.6 | -4.2 | |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -4.2 | -9.1 | -11.6 | -4.2 | |
| Net margin | -491.5% | -1299.8% | -1717.6% | -6979.7% | |
| |
| Diluted EPS | ($1.68) | ($4.67) | ($0.59) | ($0.27) | |
| Shares outstanding (diluted) | 2.5 | 1.9 | 19.5 | 15.4 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|